Alzheimer’s disease will become eligible for treatment with medical marijuana in Minnesota next year, making it the 14th health condition approved since the state’s cannabis program began in 2015.

The Minnesota Department of Health announced Monday that it was adding the degenerative neurological disorder to the program, despite limited evidence on the effectiveness of treatment with cannabis.

Some studies have found that marijuana inhibits the formation of tau proteins that accelerate dementia and memory loss related to the disease.

Click here to read the complete article

Jeremy Olson ~ Star Tribune ~

Recent News Articles

Monday February 25

First Clinical Trial Of Cannabis For PTSD in Veterans Is Now Complete - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

After a decade of working on the first FDA-approved trial examining the effects of THC…

862 hits

Monday February 25

Here's How Many Cannabis Consumers There Are in Canada - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

According to the federal statistics office, nearly one in six Canadians (15.4 percent) have consumed…

1107 hits

Monday February 25

Cannabis And Lou Gehrig’s Disease: Here’s What You Should Know - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

ALS (also known as Lou Gehrig’s Disease) is a fatal motor neuron disease, affecting an…

1118 hits

Monday February 25

UConn’s cannabis growing course sheds light on a plant once kept in the shadows -…

in Culture & Arts

by Bruce Kennedy - Editor in Chief

By the end of this semester’s inaugural class of “Horticulture of Cannabis: From Seed to…

1115 hits

Tuesday February 26

Cannabis may be coming to a mall near you: rolling papers and CBD products go…

in Finance

by Bruce Kennedy - Editor in Chief

Cannabis is not just going mainstream. It’s going upscale.

899 hits